Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Sharon R. Hymes Image

      Sharon R. Hymes, M.D.

      Department of Dermatology, Division of Internal Medicine - Clinical

      Present Title & Affiliation

      Primary Appointment

      Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1976Baylor College of Medicine, Houston, Texas, US, MD
      1973Cornell University, Ithaca, New York, US, Neurobiology, BS

      Postgraduate Training

      1982-1983Postdoctoral Fellowship, Dermatopathology, The Johns Hopkins Hospital, Baltimore, Maryland
      1980-1982Postdoctoral Residency, Dermatology, The Johns Hopkins Hospital, Baltimore, Maryland
      1979-1980Postdoctoral Residency, Dermatology, The University of Washington Hospital, Seattle, Washington
      1976-1979Postdoctoral Internship and Residency, Internal Medicine, The Johns Hopkins Hospital, Baltimore, Maryland

      Licenses & Certifications

      2025CITI Program Course
      2025Basic Life Support
      2023DEA Registration
      2006Texas
      1983American Board of Dermatology
      1979American Board of Internal Medicine
      nullFlorida

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Dermatology, M.D. Anderson Cancer Center and The University of Texas Medical School, Houston, TX, 2001 - 2006

      Associate Professor, Dermatology, The University of Texas-Houston Medical School Clinic / Attending Dermatologist & Coordinator of Dermatology, Sugar Land, TX, 1996 - 2001

      Associate Professor, Dermatology, The University of Texas Houston Medical School, Sugar Land, TX, 1993 - 2001

      Assistant Professor, Dermatology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1988 - 1993

      Assistant Professor, Dermatology, The University of South Florida Medical School, The Attending Dermatologist and Coordinator of the Pigmented Lesion Clinic at the H.Lee Moffitt Cancer Center, Tampa, FL, 1985 - 1988

      Assistant Professor, Dermatology, The University of Texas - Houston Medical School, Houston, TX, 1983 - 1985

      Instructor, Dermatology, The Johns Hopkins Hospital, Baltimore, MD, 1982 - 1983

      Administrative Appointments/Responsibilities

      Associate Medical Director, Dermatology, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2022

      Other Professional Positions

      Active Staff, Lyndon B. Johnson General Hospital, Houston, TX, 1990 - Present

      Active Staff, Memorial Hermann Hospital, Houston, TX, 1988 - Present

      Active Staff, The University of Texas MD Anderson Cancer Center, Houston, TX, 1988 - Present

      Extramural Institutional Committee Activities

      Participant, Cutaneous Imaging Work Group, The University of Texas MD Anderson Cancer Center, 2015 - Present

      Study Chairmen, GVHD Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2018

      Alternate Representative, Credentialing Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2013 - Present

      Member, GVHD Focus Group, The University of Texas MD Anderson Cancer Center, 2008 - Present

      Member, The Clinical Faculty Reviewer Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2012

      Member, Multi-year Award Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2012

      Member, Senate Education Committee, The University of Texas MD Anderson Cancer Center, 2006 - Present

      Member, Faculty Senate Bylaws Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2012

      Member, The New Faculty Achievement Awards Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2007

      Reviewer, Faculty Reviewer, The University of Texas MD Anderson Cancer Center, 2005 - 2008

      Member, Cancer Center Support Grant, The University of Texas MD Anderson Cancer Center, 2004 - Present

      Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2002 - 2011

      Member, Skin Cancer Prevention and Detection Advisory Committee, Department of Professional Education for Prevention and Early Detection, The University of Texas MD Anderson Cancer Center, 1994 - 2001

      Member, Quality Excellence Committee for the Outpatient Clinics, The University of Texas MD Anderson Cancer Center, 1991 - 1992

      Interviewer, Faculty Interviewer, The University of Texas MD Anderson Cancer Center, 1983 - Present

      Honors & Awards

      2021 - 2025Top Performer - PRS Annual Business Meeting & Recognition Awards, M.D. Anderson Cancer Center
      2020 - 2025Super Doctors Hall of Fame 2020, Texas Super Doctors
      2020 - 2025Top Performer Award, PRS Annual Business Meeting & Awards
      2019 - 2025Top 1% Provider: Patient Experience Awards 2019
      2018 - 2025Top Performer Award, PRS Annual Business Meeting & Awards
      2018 - 2025Faculty Excellence in Patient Care, UT MD Anderson Cancer Center
      2018 - 2025Top Performer Award, UT MD Anderson Cancer Center
      2018 - 2025Top 1% Provider, UT MD Anderson Cancer Center
      2017 - 20252017 Top Performer, MD Anderson
      2015 - 2025Top Dermatologist In Houston, TX, International Association of Dermatologists (IAD)
      2013Prize Winning Poster: Development of New Melanomas and Atypia in Pre-existing Nevi in Patients Undergoing BRAF-Inhibitor Therapy, Texas Dermatological Society
      2012Best Doctors, In America
      2011 - 2025Texas Super Doctors, Texas Monthly Magazine
      2011 - 2013Best Doctors, US News and World Reports
      2006Recipient of Multi-year Award, M. D. Anderson Cancer Center
      1979Internal Medicine Teaching Citation, The Johns Hopkins Hospital
      1976Janet M. Glasgow Award of Achievement, American Medical Women’s Association
      1975 - 1976Alpha Omega Alpha, Baylor College of Medicine
      1973Dean’s List, Cornell University
      1969New York State Merit Scholarship
      1969National Merit Scholarship

      Professional Memberships

      Dermatology OneConnect Enhancements: Go-Live Committee

      2020 - Present

      Credentials Committee of the Medical Staff Member and Alternate

      2015 - Present

      Steering Committee

      2015 - Present

      Epic Medical Photography Committee

      2015 - Present

      Melanoma Continuity of Care Committee

      2015 - Present

      GVHD Committee

      2015 - Present

      Faculty Appeals Committee

      2015 - Present

      Continuity of care committee for melanoma

      2015 - Present

      Dr. Liu’s Review Committee for her Mid-cycle review

      2014 - 2014

      American Dermatological Association

      2014

      MDACC - Faculty Appeals Committee for Dermatology

      2013 - Present

      Credentialing Committee of Medical Staff

      2013 - 2016

      Credentials Committee of the Medical Staff

      2013 - 2014

      Clinical Process Analysis Committee

      2012

      Texas Super Doctors 2012- 2018

      2012 - 2018

      Texas Dermatological Society

      2010 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2021. It Takes a Village: Chronic Cutaneous and Oral GVHD – A Multidisciplinary Approach to Diagnosis and Patient Care. Conference. Internal Medicine and Cancer Survivorship Grand Rounds:. Houston, TX, US.
      2. 2019. GVHD. Conference. UT and Baylor College of Medicine. Houston, TX, US.
      3. 2019. Blastic Plasmacytoid Rendritic Cell Neoplasma Presenting as lethyosis. Conference. Texas Dermatologic Society. Houston, TX, US.
      4. 2019. Paraneoplastic Permphique. Conference. Houston Dermatological Society. Houston, TX, US.
      5. 2019. Reduction induced Morphea. Conference. Texas Dermatologic Society. Houston, TX, US.
      6. 2015. Melanoma/Skin/Dermatology Photographic Work Flow Meeting. Conference. MD Anderson. Houston, TX, US.
      7. 2014. Radiation Dermatitis 2014. Conference. Baylor. Houston, TX, US.
      8. 2014. Gvhd Teaching Conference Part 2of 2. Conference. Baylor/UT. Houston, TX, US.
      9. 2014. Gvhd Teaching Conference Part I of 2. Conference. Baylor/UT. Houston, TX, US.
      10. 2013. KIDD Syndrome. Conference. Texas Dermatological Society. Houston, TX, US.
      11. 2012. Early Detection and Prevention. Conference. Melanoma Research Foundation. Houston, TX, US.
      12. 2012. UT Rounds on Radiation Dermatitis. Conference. Baylor College of Medicine. Houston, TX, US.
      13. 2012. Graft versus host disease, future directions. Conference. Baylor College of Medicine. Houston, TX, US.
      14. 2012. Cutaneous Graft-versus-Host Disease. Conference. MD Anderson Cancer Center. Houston, TX, US.
      15. 2011. Non-Melanoma Skin Cancer. Conference. Baylor College of Medicine. Houston, TX, US.
      16. 2010. Radiation for Dermalogists. Conference. Radiation for Dermalogists. Houston, TX, US.
      17. 2010. "Adverse Manifestations of Tyrosine Kinase Inhibitors". Conference. MD Anderson Cancer Center. Houston, TX, US.
      18. 2009. Phototherapy in the Oncology Setting. Conference. MDACC Nursing Rounds. Houston, TX, US.
      19. 2009. GVHD, history and new insights. Conference. Joint Baylor and UT Derm Conference. Houston, TX, US.

      Regional Presentations

      1. 2014. Bullous dermatosis of the mouth. Conference. Texas Dermatology Society. Bastrop, TX, US.
      2. 2013. Development of New Melanomas and Atypia in Pre-existing Nevi in Patients Undergoing BRAF-Inhibitor Therapy. Conference. Texas Dermatological Society. Galveston, TX, US.
      3. 2013. EPPER Syndrome. Conference. Texas Dermatological Society. Galveston, TX, US.
      4. 2003. Management of Cutaneous Reactions Associated with Amifostine. Conference. The American Society of Clinical Oncology, US.

      National Presentations

      1. 2022. Protecting Your Skin After Transplantation. Invited. Bone Marrow Transplant Survivorship Symposium. Virtual, US.
      2. 2022. Chronic Graft-versus-Host Disease of the Skin and Connective Tissue. Invited. Bone Marrow Transplant Survivorship Symposium. Virtual, US.
      3. 2017. Graft versus Host Disease: A dermatologic perspective. Invited. Memorial Sloan Kettering Cancer Center. New York City, NY, US.
      4. 2015. Acute GVHD. Invited. American Academy of Dermatology. San Francisco, CA, US.
      5. 2014. Cutaneous EBV-positive post-transplant lymphoproliferative disorder. Invited. Texas dermatology society. Fort Worth, TX, US.
      6. 2013. Graft Versus Host Disease. Invited. 71st AAD Annual Meeting. Miami, FL, US.
      7. 2012. Papillary Thyroid Carcinoma Metastatic to the Skin. Conference. 70th AAD Annual Meeting. San Diego, CA, US.
      8. 2011. Graft versus Host Disease. Invited. 69th AAD Annual Meeting. New Orleans, LA, US.
      9. 2010. Linear Graft versus Host Disease. Conference. 57 Annual Zola Cooper clinical and dermatopathologic seminar. New Orleans, LA, US.
      10. 2010. Detection of Human Papillomavirus in Multiple Eccrine Poromas in a Patient with Chronic Graft-Vs-Host Disease and Immunosuppression. Conference. Texas Dermatology Society. Houston, TX, US.
      11. 2010. Photodynamic Therapy for Arsenical Keratoses. Invited. 68th AAD Annual Meeting / Poster. Miami, FL, US.
      12. 2008. The Diagnosis and Treatment of Skin Cancer, The Westin Oaks Hotel. Invited. Texas Academy of Family Physicians, Primary Care Summit. Houston, TX, US.
      13. 2008. Skin Effects of Biologically Targeted Cancer Therapy. Invited. 66th AAD Annual Meeting. San Antonio, TX, US.
      14. 2008. Skin Cancer. Conference. Primary Care Physician Summit. Houston, TX, US.
      15. 2007. Extended-Field Irradiation and Intracavitary Brachytherapy Combined With Cisplatin and Amifostine for Cervical Cancer With Positive Para-Aortic or High Common Iliac Lymph Nodes: Results of Arm II of RTOG 0116. Invited. ASTRO. Los Angeles, CA, US.
      16. 2007. Chronic Graft vs Host Disease. Invited. 65th AAD Annual Meeting. Washington, DC, US.
      17. 2006. Radiation Dermatitis. Invited. 64th AAD Annual Meeting. San Francisco, CA, US.
      18. 2005. Radiation Dermatitis. Invited. 63rd AAD Annual Meeting. New Orleans, LA, US.
      19. 2004. Skin Cancer. Invited. Primary Care Physician Summit. Houston, TX, US.
      20. 2004. Erthema Nodosum TB or not TB. Invited. 62nd AAD Annual Meeting. Washington, DC, US.
      21. 2003. Graft Versus Host Disease. Invited. Joint dermatology conference of Baylor and UTHSC. Houston, TX, US.
      22. 2003. Radiation Dermatitis and Breast Cancer. Invited. 61 AAD Annual Meeting. San Francisco, CA, US.
      23. 2003. Infections in Atopic Dermatitis. Invited. Houston Novartis Conference. Houston, TX, US.
      24. 2001. The Immunology of Eczema and Psoriasis. Invited. The University of South Florida Medical School, FL, US.
      25. 2000. Dermatology for the Internist. Invited. Internal Medicine 2000:Update and Board Review. Houston, TX, US.
      26. 1999. Dermatology for the Internist” Internal Medicine 1999. Invited. Internal Medicine 1999:Update and Board Review. Houston, TX, US.
      27. 1998. Dermatology for the Internist. Invited. Internal Medicine 1998:Update and Board Review. Houston, TX, US.
      28. 1997. Dermatology for the Internist. Invited. Internal Medicine 1997: Update and Board Review. Houston, TX, US.
      29. 1993. Some Important Photosensitive Disorders. Invited. Texas Dermatological Society - Spring Meeting. Houston, TX, US.
      30. 1992. Management and Assessment of Commonly Occurring Skin Conditions. Invited. Texas Nurse Practitioners Conference - 1992 Annual Meeting. Houston, TX, US.
      31. 1988. Neonatal Lupus Erythematosus. Invited. Florida Conference on Dermatology and Dermatologic Surgery. Orlando, FL, US.
      32. 1987. Hypersensitivity Reactions. Invited. Allergy Grand Rounds. Tampa, FL, US.
      33. 1986. Neonatal Dermatology. Invited. Pediatric Grand Rounds. Tampa, FL, US.
      34. 1986. Graft-Versus-Host Disease. Invited. Medical Grand Rounds. Tampa, FL, US.
      35. 1985. Graft-Versus-Host Disease. Invited. American Academy of Dermatology - Annual Meeting - Symposium on Immunology. Las Vegas, NV, US.
      36. 1983. Prognostic Features in Cutaneous Graft-Versus-Host Seen by Light Microscopy. Invited. American Academy of Dermatology/Dermatopathology - Annual Meeting. Chicago, IL, US.

      International Presentations

      1. 2019. Radiation induce morphea”. Conference. Texas Dermatologic Association meeting. Houston, US.
      2. 2016. GVHD - Graft versus Host Disease. Invited. Albert Eistein Instituto Israelita de Ensino e Pesquisa. Fortaleza, BR.
      3. 2015. BRAFI association melanocytic lesions_USCAP. Conference. United States and Canadian Academy of Pathology. Houston, US.
      4. 2007. "Cutaneous Graft Versus Host Disease". Conference. 21st World Congress of Dermatology. Wilmington, US.
      5. 1988. Atrophoderma of Pasini and Pierini. Invited. Southeastern Dermatological Association - Annual Meeting. St. Petersburg, US.

      Formal Peers

      1. 2019. 24th World Congress Of Dermatology. Invited. Milan, IT.
      2. 2019. Graft versus Host Disease. Invited, US.
      3. 2017. UT GVHD. Visiting. houston, TX, US.
      4. 2017. GVHD talk. Visiting. Houston, TX, US.
      5. 2017. Graft versus Host Disease: A dermatologic perspective. Invited. New York, NY, US.
      6. 2017. Acute graft versus host disease at Bone Marrow Transplant. Visiting. Orlando, FL, US.
      7. 2016. Acute GVHD Lecture. Visiting. Houston, TX, US.
      8. 2015. UT GVHD Part 1. Visiting. Houston, TX, US.
      9. 2015. UT GVHD Part 2. Visiting. Houston, TX, US.
      10. 2015. Brazil stem cell transplant symposium GVHD. Invited. Iguassu Falls, BR.
      11. 2015. Epic Medical photography. Visiting. Houston, TX, US.
      12. 2015. Melanoma Continuity of Care. Visiting. Houston, TX, US.
      13. 2014. GVHD: A 30 year perspective. Invited, VA, US.
      14. 2013. Graft vs Host Disease: Clinical and Pathologic Correlations. Visiting. Sao Paulo, BR.
      15. 2012. Melanoma Patient Symposium. Visiting. Houston, TX, US.
      16. 2012. Graft-versus-host disease. Visiting. Houston, TX, US.
      17. 2012. GI and Cutaneous Graft vs Host Disease. Invited. Houston, TX, US.
      18. 2012. Acute GVHD lecture. Visiting. Houston, TX, US.
      19. 2011. “Detection and Treatment of Skin Cancer”. Invited. Houston, TX, US.
      20. 2011. Evaluation and Treatment of Non-Melanoma Skin Cancer: A Dermatology Point of View. Invited, US.
      21. 2009. "Cutaneous Side Effects of Tyrosine Kinase Inhibitors". Invited, US.
      22. 2009. "Radiation Dermatitis" Medical Issues in Cancer Survivors. Invited, US.
      23. 2007. Identification of Primary Melanoma Lesions. Invited. Houston, TN, US.
      24. 2007. Lichenoid Dermatitis from Interferon alpha-2a in a patient with metastasis renal cell carcinoma. Invited. Houston, TX, US.
      25. 2006. Cutaneous Graft-versus-Host at Dermatology Department Ground Rounds at Duke University. Invited. North Carolina, NC, US.
      26. 2006. Dermatology for the Internist - Internal Medicine 2000:. Invited. Houston, TX, US.
      27. 1999. Dermatology for the Internist, Internal Medicine 1999:. Invited. Houston, TX, US.
      28. 1998. Dermatology for the Internist Internal Medicine 1998:. Invited. Houston, TX, US.
      29. 1997. Dermatology for the Internist. Invited. Houston, TX, US.
      30. 1994. Evaluation and Management of Commonly Occurring Skin Conditions. Invited. Houston, TX, US.
      31. 1993. Introduction to Cutaneous Diseases. Invited. Houston, TX, US.
      32. 1993. Important Photosensitive Skin Disorders. Invited. Houston, TX, US.
      33. 1992. Management and Assessment of Commonly Occurring Skin Conditions.". Invited. Houston, TX, US.
      34. 1988. "Neonatal Lupus Erythematosus.". Invited. Orlando, FL, US.
      35. 1987. Hypersensitivity Reactions. Invited. Tampa, FL, US.
      36. 1986. "Neonatal Dermatology.". Invited. Tampa, TX, US.
      37. 1986. Graft Versus Host Disease. Invited. Tampa, FL, US.
      38. Speaker Program. Invited, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Ronen S, Keiser E, Collins KM, Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Hymes S, Medeiros LJ, Torres-Cabala CA. Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive review. J Cutan Pathol 48(4):547-557, 2021. e-Pub 2021. PMID: 32644218.
      2. Pinney SS, Kauffman J, Hymes SR. Painful rash in a screaming toddler. Emerg Med J 36(11):696-704, 2019. e-Pub 2019. PMID: 31641040.
      3. Ciurea SO, Hansrivijit P, Ciurea AM, Hymes S, Chen J, Rondon G, Hosing C, Popat U, Champlin RE. Curative Potential of Hematopoietic Stem Cell Transplantation for Advanced Psoriasis. Am J Hematol 94(6):E176-E180, 2019. e-Pub 2019. PMID: 30900768.
      4. Arudra K, Patel R, Tetzlaff MT, Hymes S, Subbiah V, Meric-Bernstam F, Torres-Cabala C, Aung PP, Nagarajan P, Diab A, Prieto VG, Nelson K, Curry JL. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. J Cutan Pathol 45(10):786-790, 2018. e-Pub 2018. PMID: 30021048.
      5. Petersen E, Yazdani L, Hymes SR. A case of radiation-induced bullous morphea/lichen sclerosus overlap in a breast cancer patient. Rep Pract Oncol Radiother 23(1):47-49, 2018. e-Pub 2018. PMID: 29872368.
      6. Nadeem S, Hymes S, Kebriaei P, Duvic M, Abruzzo L, Curry J. Alopecia areata after human leukocyte antigen identical bone marrow transplantation from an affected, sibling donor. Bone Marrow Transplantation 23:47-49, 2018. e-Pub 2018.
      7. Bush AE, Hymes SR, Silapunt S. Lichenoid Dermatitis From Interferon alpha-2a in a Patient With Metastatic Renal Cell Carcinoma and Seronegative HCV. J Drugs Dermatol 16(7):714-716, 2017. e-Pub 2017. PMID: 28697228.
      8. Falchook GS, Rady P, Konopinski JC, Busaidy N, Hess K, Hymes S, Nguyen HP, Prieto VG, Bustinza-Linares E, Lin Q, Parkhurst KL, Hong DS, Sherman S, Tyring SK, Kurzrock R. Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors. Arch Dermatol Res 308(5):357-65, 2016. e-Pub 2016. PMID: 27098388.
      9. Mudaliar K, Tetzlaff MT, Duvic M, Ciurea A, Hymes S, Milton DR, Tsai KY, Prieto VG, Torres-Cabala CA, Curry JL. BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Hum Pathol 50:79-89, 2016. e-Pub 2016. PMID: 26997441.
      10. Wolf J, Sun Y, Tang L, Newland JG, Gerber JS, Van Dyke CJ, Hymes SR, Yu D, Carias DC, Bryant PA, Interest Group PHAS. Antimicrobial Stewardship Barriers and Goals in Pediatric Oncology and Bone Marrow Transplantation: A Survey of Antimicrobial Stewardship Practitioners. Infect Control Hosp Epidemiol 37(3):343-7, 2016. e-Pub 2016. PMID: 26639441.
      11. Kaffenberger BH, Zuo RC, Gru A, Plotner AN, Sweeney SA, Devine SM, Hymes SR, Cowen EW. Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity. J Am Acad Dermatol 71(14-00229R2):745-53, 2014. e-Pub 2014. PMID: 24993601.
      12. Wuu A, Bangert SD, Weber DM, Hymes SR. Primary cutaneous plasmacytoma. Cutis 93(6):E19-21, 2014. e-Pub 2014. PMID: 24999652.
      13. Nadeem S, Hymes S, Kebriaei P, Abruzzo L, Curry JL, Duvic M. Alopecia areata after HLA-identical BMT from an affected, sibling donor. Bone Marrow Transplant 49(4):592-4, 2014. e-Pub 2014. PMID: 24442249.
      14. Falchook GS, Rady P, Hymes S, Nguyen HP, Tyring SK, Prieto VG, Hong DS, Kurzrock R. Merkel cell polyomavirus and HPV-17 associated with cutaneous squamous cell carcinoma arising in a patient with melanoma treated with the BRAF inhibitor dabrafenib. JAMA Dermatol 149(3):322-6, 2013. e-Pub 2013. PMID: 23552670.
      15. Hooven TA, Randis TM, Hymes SR, Rampersaud R, Ratner AJ. Retrocyclin inhibits Gardnerella vaginalis biofilm formation and toxin activity. J Antimicrob Chemother 67(12):2870-2, 2012. e-Pub 2012. PMID: 22855857.
      16. Baird JS, Buet A, Hymes SR, Ravindranath TM, Zackai S, Cannon JM, Messina M, Sury J, Green R, Della-Latta P, Jenkins SG, Greenwald BM, Furuya EY, Graham PL, Sonnett FM, Platt S, DeLaMora P, Saiman L. Comparing the clinical severity of the first versus second wave of 2009 Influenza A (H1N1) in a New York City pediatric healthcare facility. Pediatr Crit Care Med 13(4):375-80, 2012. e-Pub 2012. PMID: 22198811.
      17. Alexander LJ, Paravar T, Duvic M, Prieto V, Hymes SR. Annular plaques: An unusual manifestation of graft-versus-host disease. Dermatol Online J 18(6):4, 2012. e-Pub 2012. PMID: 22747928.
      18. Sweeney SA, Kumar VA, Tayar J, Weber DM, Safdar A, Alonso C, Hymes S. Case 181: Synovitis Acne Pustulosis Hyperostosis Osteitis (SAPHO) Syndrome. Radiology 263(2):613-7, 2012. e-Pub 2012. PMID: 22517965.
      19. Hymes SR, Alousi AM, Cowen EW. Graft-versus-Host Disease Part I: Pathogenesis and clinical manifestations of graft-versus-host disease. J Am Acad Dermatol 66(4):515.e1-18; quiz 533-4, 2012. e-Pub 2012. PMID: 22421123.
      20. Hymes SR, Alousi AM, Cowen EW. Graft-versus-Host Disease Part II: Management of cutaneous graft-versus-host disease. J Am Acad Dermatol 66(4):535.el-535.e16.3, 2012. e-Pub 2012. PMID: 22421124.
      21. Kauffman JA, Ivan D, Cutlan JE, Hymes SR. Actinic granuloma occurring as an unusual association with cutaneous B-cell chronic lymphocytic leukemia. J Cutan Pathol 39(2):294-7, 2012. e-Pub 2012. PMID: 22077555.
      22. Viswanathan AN, Moughan J, Small W, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer 22(1):123-131, 2012. e-Pub 2012. PMID: 22193645.
      23. Small W, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K. Extended-Field Irradiation and Intracavitary Brachytherapy Combined With Cisplatin and Amifostine for Cervical Cancer With Positive Para-Aortic or High Common Iliac Lymph Nodes: Results of Arm II of RTOG 0116. Int J Gynecol Cancer 21(7):1266-75, 2011. e-Pub 2011. PMID: 21892091.
      24. Alousi A, Ghosh S, Rice D, Moran C, Manning JT, Iliescu C, Hymes S, Kim S, Bashoura L, Kornblau S, Dickey BF. Pleuropericarditis, obliterative bronchiolitis and lymphocytic interstitial pneumonitis after allogeneic haematopoietic stem cell transplantation. BMJ Case Rep 2011(doi:10.1136/bcr.11.2010.3488):1of4, 2011. e-Pub 2011. PMID: 22707568.
      25. Diamantis ML, Richmond HM, Rady PL, Tyring SK, Cutlan JE, Torres-Cabala C, Hymes SR. Detection of Human Papillomavirus in Multiple Eccrine Poromas in a Patient with Chronic Graft-Versus Host Disease and Immunosuppression. Arch Dermatol 147(1):120-122, 2011. e-Pub 2011. PMID: 21242407.
      26. Geddes ER, Polder K, Cutlan JE, Torres-Cabala CA, Hymes SR. Ulcerated Plaque under a Ruby Ring in an Immunosuppressed Patient. Dermatol Online J 16(8):4, 2010. e-Pub 2010. PMID: 20804681.
      27. Paravar T, Hymes SR. Longitudinal melanonychia induced by capecitabine. Dermatol Online J 15(10):5, 2009. e-Pub 2009. PMID: 19951629.
      28. Rashid R, Hymes S. Folliculitis, follicular mucinosis, and papular mucinosis as a presentation of chronic myelomonocytic leukemia. Dermatol Online J 15(5):16, 2009. e-Pub 2009. PMID: 19624994.
      29. Braiteh F, Hymes SR, Giralt SA, Jones R. Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma. J Clin Oncol 26(27):4511-4513, 2008. e-Pub 2008. PMID: 18802165.
      30. Chrastil B, Fornage B, Nash J, Hymes SR. A Black Plaque on the Toe of a White Male. Int J Dermatol 47(9):977-8, 2008. e-Pub 2008. PMID: 18937671.
      31. Santarpia L, El-Naggar AK, Sherman SI, Hymes SR, Gagel RF, Shaw S, Sarlis NJ. Four patients with cutaneous metastases from medullary thyroid cancer. Thyroid 18(8):901-5, 2008. e-Pub 2008. PMID: 18651821.
      32. Madkan W, Hymes S. The Clinical Appearance of Multi-Drug Resistant Herpes Simplex in an Immuncompromised Patient. Drugs in Dermatology, 2008. e-Pub 2008.
      33. Kunishige JH, Hymes SR, Madkan V, Wyatt AJ, Uptmore D, Lazar AJ, Giralt S, Rady P, Tyring S. Epidermodysplasia verruciformis in the setting of graft-versus-host disease. J Am Acad Dermatol 57(5 Suppl):S78-S80, 2007. e-Pub 2007. PMID: 17938030.
      34. Yee KW, Hymes SR, Heller L, Prieto VG, Welch MA, Giles FJ. Cutaneous leukocytoclastic vasculitis in a patient with myelodysplastic syndrome after therapy with the rapamycin analogue everolimus: case report and review of the literature. Leuk Lymphoma 47(5):926-9, 2006. e-Pub 2006. PMID: 16753882.
      35. Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, Smith V, Khouri I, Giralt S, de Lima M, Hsu Y, Ghosh S, Neumann J, Andersson B, Qazilbash M, Hymes S, Kim S, Champlin R, Donato M. Extracorporeal photochemotherapy for the treatment of steroid resistant chronic GVHD. Blood 107(8):3074-80, 2006. e-Pub 2006. PMID: 16368882.
      36. Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, Mittelman B, Pavletic S, Vogelsang GB, Martin PJ, Lee SJ, Flowers ME. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 12(4):375-96, 2006. e-Pub 2006. PMID: 16545722.
      37. Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G, Flowers ME, Turner M, Atkinson J, Lefkowitch J, Washington MK, Prieto VG, Kim SK, Argenyi Z, Diwan AH, Rashid A, Hiatt K, Couriel D, Schultz K, Hymes S, Vogelsang GB. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 12(1):31-47, 2006. e-Pub 2006. PMID: 16399567.
      38. Jih MH, Friedman PM, Kimyai-Asadi A, Friedman ES, Hymes SR, Goldberg LH. Lupus Miliaris Disseminatus Faciei: treatment with the 1450-nm diode laser. Arch Dermatol 141(2):143-145, 2005. e-Pub 2005. PMID: 15724009.
      39. Thurber M, Feasel A, Stroehlein J, Hymes SR. Pustular Psoriasis Induced by Infliximab. J Drugs Dermatol 3(4):39-440, 2004. e-Pub 2004. PMID: 15303790.
      40. Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, Trancik RJ, Bandstra BA, Compton LD. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 35(1):74-78, 1996. e-Pub 1996. PMID: 8682968.
      41. Vine JE, Hymes SR, Warner NB, Cohen PR. Pustular psoriasis induced by hydroxychloroquine; A case report and review of the literature. J Dermatol 23(5):357-361, 1996. e-Pub 1996. PMID: 8675829.
      42. Meyerson MA, Cohen PR, Hymes SR. Lingual hyperpigmentation associated with minocycline therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79(2):180-184, 1995. e-Pub 1995. PMID: 7614181.
      43. Phillips DK, Hymes SR. Recurrent facial plaques following full-thickness grafting. Granuloma faciale. Arch Dermatol 130(11):1433-4, 1436-7, 1994. e-Pub 1994. PMID: 7979448.
      44. Cohen PR, Hymes SR. Linear and dermatomal cutaneous graft-versus-host disease. South Med J 87(7):758-761, 1994. e-Pub 1994. PMID: 8023213.
      45. Dhingra K, Duvic M, Hymes S, McLaughlin P, Rothberg J, Gutterman JU. A phase-I clinical study of low-dose oral interferon-alpha. J Immunother Emphasis Tumor Immunol 14(1):51-5, 1993. e-Pub 1993. PMID: 8399070.
      46. Hymes SR, Jordon RE. Pemphigus foliaceus: use of antimalarial agents as adjuvant therapy. Arch Dermatol 128(11):1462-1464, 1992. e-Pub 1992. PMID: 1444499.
      47. Schauder CS, Hymes SR, Rapini RP, Zipf TF. Vesicular graft-versus-host disease. Int J Dermatol 31(7):509-510, 1992. e-Pub 1992. PMID: 1500247.
      48. Cohen PR, Hymes SR. Secondary syphilis presenting as cutaneous nodules in a patient previously treated for laryngeal carcinoma. Cutis 49(1):51-4, 1992. e-Pub 1992. PMID: 1733660.
      49. Magee KL, Hymes SR, Rapini RP, Yeakley JW, Jordon RE. Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol 24(2):288-290, 1991. e-Pub 1991. PMID: 2007680.
      50. Murphy PK, Hymes SR, Fenske NA. Concomitant unilateral idiopathic atrophoderma of Pasini and Pierini (IAPP) and morphea. Observations supporting IAPP as a variant of morphea. Int J Dermatol 29(4):281-283, 1990. e-Pub 1990. PMID: 2370118.
      51. Norman J, Cruse W, Ruas E, Beatty E, Hymes S, Espinosa C, Clark R, Reintgen D. The expanding role of lymphoscintigraphy in the management of cutaneous melanoma. First Place Winner: Conrad Jobst award. Am Surg 55(12):689-94, 1989. e-Pub 1989. PMID: 2596765.
      52. Hymes SR, Jordon RE, Arnett FC. Lupus erythematosus. Dermatol Clin 4(2):267-276, 1986. e-Pub 1986. PMID: 3955897.
      53. Hymes SR, Farmer ER, Burns WH, Morison WL, Tutschka PJ, Walters LL, Santos GW. Bullous sclerodermalike changes in chronic graft-vs-host disease. Arch Dermatol 121(9):1189-92, 1985. e-Pub 1985. PMID: 3899019.
      54. Hymes SR, Simonton SC, Farmer ER, Beschorner WB, Tutschka PJ, Santos GW. Cutaneous busulfan effect in patients receiving bone marrow transplantation. J Cutan Pathol 12(2):125-129, 1985. e-Pub 1985. PMID: 3889081.
      55. Hymes SR, Farmer ER, Lewis PG, Tutschka PJ, Santos GW. Cutaneous graft-versus-host reaction: Prognostic features seen by light microscopy. J Am Acad Dermatol 12(3):468-474, 1985. e-Pub 1985. PMID: 3989008.
      56. Hymes SR, Morison WL, Farmer ER, Walters LL, Tutschka PJ, Santos GW. Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction. J Am Acad Dermatol 12(1 Pt 1):30-7, 1985. e-Pub 1985. PMID: 3980801.

      Review Articles

      1. Curry JL, Tetzlaff MT, Nagarajan P, Drucker C, Diab A, Hymes SR, Duvic M, Hwu WJ, Wargo JA, Torres-Cabala CA, Rapini RP, Prieto VG. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol 44(2):158-176, 2017. e-Pub 2017. PMID: 27859479.
      2. Wright NA, Torres-Cabala CA, Curry JL, Cutlan JE, Hymes SR. Post-varicella-zoster virus granulomatous dermatitis: a report of 2 cases. Cutis 93(1):50-4, 2014. e-Pub 2014. PMID: 24505586.
      3. Fox MC, Carter S, Khouri IF, Giralt SA, Prieto VG, Nash JW, Hymes SR. Adult Henoch-schönlein purpura in a patient with myelodysplastic syndrome and a history of follicular lymphoma. Cutis 81(2):131-7, 2008. e-Pub 2008. PMID: 18441766.
      4. Mays SR, Kunishige JH, Truong E, Kontoyiannis DP, Hymes SR. Approach to the Morbilliform Eruption in the Hematopoietic Transplant Patient. Semin Cutan Med Surg 26(3):155-62, 2007. e-Pub 2007. PMID: 18070682.
      5. Hymes SR, Turner ML, Champlin RE, Couriel DR. Cutaneous Manifestations of Chronic Graft Versus Host Disease. Biol Blood Marrow Transplant 12(11):1101-13, 2006. e-Pub 2006. PMID: 17085303.
      6. Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 54(1):28-46, 2006. e-Pub 2006. PMID: 16384753.
      7. Boccia R, Anné PR, Bourhis J, Brizel D, Daly C, Holloway N, Hymes S, Koukourakis M, Kozloff M, Turner M, Wasserman T. Assessment and Management of Cutaneous Reactions with Amifostine Administration: Findings of the ethyol (amifostine) Cutaneous treatment advisory panel (ECTAP). Int J Radiat Oncol Biol Phys 60(1):302-9, 2004. e-Pub 2004. PMID: 15337569.
      8. Hymes SR, Jordon RE. Chronic cutaneous lupus erythematosus. Med Clin North Am 73(5):1055-71, 1989. e-Pub 1989. PMID: 2671532.
      9. Hymes SR, Russell TJ, Jordon RE. The anti-Ro antibody system. Int J Dermatol 25(1):1 - 7, 1986. e-Pub 1986. PMID: 3512458.

      Professional Educational Materials

      1. . American Academy of Dermatology for Self Assessment CME Program, 2004.
      2. Hymes SR. Dermatology and Internal Medicine for Medical Students, 2004.
      3. Hymes SR. Dermatology for Internists, University of Texas Medical School Houston, 2000.

      Abstracts

      1. Pinney S, Hymes SR. A Painful Rash in a Screaming Toddler. JEmerMed 2019. e-Pub 2019.
      2. Pye, A, Robinson, C, Kash, N, Torres-Cabala C, Hymes, SR. Blastic Plasmacytoid Dendritic Cell Neoplasm Manifesting as Ichthyosis. Texas Dermatological Society Meeting, September 21, 2018, 2018. e-Pub 2018.
      3. Diamantis M, Richmond H, Rady P, Tyring S, Cutlan J, MD, Torres-Cabaala C, Hymes S. Detection of Human Papillomavirus in Multiple Eccrine Poromas in a Patient with chronic graft-vs-host disease and immunosuppression. Arch Dermatology, 2010. e-Pub 2010.
      4. Paravar T, Hymes SR. Annular plaques: An unusual manifestation of graft-versus-host disease, 2010. e-Pub 2010.
      5. Hymes S, Hebert A. Photobiology, Phototherapy and Photosensitivity Diseases. 68th Annual Meeting of the American Academy of Dermatology, 2010. e-Pub 2010.
      6. Alousi AM, Rondon G, Okoroji GJ, Popat U, Silva L, Hymes S, Neumann J, Brunelle NM, Kebriaei P, Hosing C, Khouri IF, Shpall EJ, Qazilbash MH, Giralt S, Champlin RE, and Saliba RM. Acute GVHD in Older Pts, 2009. e-Pub 2009.
      7. Viswanathan A, Moughan J, Small W, Levenback C, Iyer R, et al HS. Quality of Brachytherapy Implants. ASTRO, 2009. e-Pub 2009.
      8. Cowen E, Hymes SR. Cutaneous Chronic GvHD. Principles and Practice of Interdisciplinary Management, 2008. e-Pub 2008.
      9. Berthelot C, Hymes SR. Multiple Endocrine Syndrome Type 2B Associated with Keloids. The Internet Journal of Dermatology, 2008. e-Pub 2008.
      10. Jr S, W, Winter, K, Levenback, C, Iyer, R, Hymes, S, Jhingran, A, Gaffney, D, Erickson, B, Greven, K. Extended Field Irradiation and Intracavitary Brachytherapy Combined with Cisplatin Chemotherapy for Cervical Cancer with Positive Para-aortic or High Common Iliac Lymph Nodes: Results of Arm 2 of RTOG 0116. RTOG ASTRO Presentation 2007 / Oct 28- Nov 1, 2007 in Los Angeles, CA, 2007. e-Pub 2007.
      11. Wang Q, Lazar A, Diwan AF, Ivan D, Hymes S, Prieto V. Graft Versus Host Disease Mimicking Erythema Dyschromicum perstans (Ashy Dermatosis). Journal of Cutaneous Pathology, 2007. e-Pub 2007.
      12. Silapunt S, Hymes SR. Lichenoid dermatitis from IFN. Presented at the 59th Annual Meeting of the Pacific Dermatology Association, 2007. e-Pub 2007.
      13. Hymes SR, Couriel D. Chronic GvHD. Presented at the International Society of Dermatology, Buenos Aires, Argentina, 2007. e-Pub 2007.
      14. Herne K, Hymes SR, Gershenwald JT. Nonmelanoma Skin Cancer. The M.D. Anderson Surgical Oncology Handbook:112-120, 2006. e-Pub 2006.
      15. Hymes SR, Couriel DR. Ancillary and Supportive Care of Chronic Cutaneous Graft versus Host Disease. NIH Consensus Development Project, 2006. e-Pub 2006.
      16. Hymes SR, Couriel DL. Chronic Graft Versus Host Disease. Dermatologic Changes of Autoimmunity. Skin, Rheumatism and Autoimmunity Meeting. Abano Terme, Italy, 2006. e-Pub 2006.
      17. Santarpia L, El-Naggar A, Hymes SR, Sherman SI, Sayegh GG, Sarlis NJ. Skin metastasis as the only de novo clinical presentation of wifely metastatic sporadic medullary thyroid carcimoma (MtC), 2006. e-Pub 2006.
      18. Bengana C, Hymes S, Lazar A. Epidermodysplasia Verruciformis-Like Features in the Setting of Graft-Versus-Host Disease. 42nd Annual Meeting of The American Society of Dermatopathology, October, 2005. e-Pub 2005.
      19. Couriel DR, Saliba R, Ghosh S, Mickler K, de Lima M, Giralt S, Khouri I, Hosing C, Andersson B, Kim S, Hymes S, Champlin R. The Clinical Spectrum of Acute GVHD: Beyond Day 100. ASH, August 2005, 2005. e-Pub 2005.
      20. Hosing C, Saliba RM, de Lima M, Giralt S, Ghosh S, Hsu Y, Anderlini P, Hymes S, Andersson B, Khouri I, Champlin R, Couriel D. Secondary Malignancy after Allogeneic Stem Cell Transplantation: Incidence and Risk Factors. 47th Annual Meeting, 2005. e-Pub 2005.
      21. Macartney Welborn BS, Reid H, MD, Sharon Hymes MD. Chronic GVHD Presenting as Blaschkoid Lichen Planus Pigmentosus, TX Dermatological Society Fall Meeting, Galveston, TX.
      22. Hymes S. Chronic Sclerodermoid Dermatosis-Associated Aggressive Cutaneous Squamous Cell Carcinomas: Report of 3 Cases.
      23. Goenaga-Vasquez, Y Farooq S, Phyu A, Hymes S. Progressive Induced Morphea Presenting 6 years later in a patient with history of breast cancer.
      24. Allison Pye MD, Caitlin Robinson MD, Natalie Kash MD, Carlos Torres-Cabala MD, Sharon Hymes MD. Blastic Plasmacytoid Dendritic Cell Neoplasm Manifesting as Ichthyosis, TX Dermatological Society Fall Meeting, Galveston, TX.

      Book Chapters

      1. Hymes, SR, Pinney S, Alousi A. Life Threatening Rashes after Hematopoietic Stem Cell Transplantation. In: Clinics of Dermatology, 2019.
      2. Hymes SR. Non-Melanoma Skin Cancer. In: The MD Anderson Surgical Oncology Handbook. 6th edition, 2018.
      3. Pinney S, Hymes SR. Clinical Presentation of Nonsclerotic Epidermal Chronic Graft-Versus-Host Disease and Hair and Nail Changes in Atlas of Graft-versus Host Disease. In: Approaches to Diagnosis and Treatment eds, 2017.
      4. Hymes SR, Curea A. Cutaneous Lesions that Mimic Infection in Organ Transplant Patients. In: Principles and Practice of Transplant Infectious Disease. Springer, 2016.
      5. Mays S, Hymes S, Cole K, Kuerer H. Skin Emergencies In the Oncology Patient. In: Oncologic Emergencies. Oncologic Emergencies, 2014.
      6. Hymes SR, Ciurea A. Skin Conditions Mistaken for Infection in the Transplant Population. In: Principles and Practice of Transplant Infectious Diseases, 2014.
      7. Hymes S, Chon S, Ciurea A. Skin Disorders Difficult to Distinguish from Infection. In: Principles and Practice of Cancer Infectious Disease. Humana Press, 233-253, 2011.
      8. Hymes SR, Drucker C. Screening,Surveillance and Prevention of Skin Cancer. In: Cutaneous Malignancy of the Head & Neck. Plural Publishing, 41-56, 2011.
      9. Hymes SR, Couriel DR. Graft-versus-Host Disease. In: Internal Medicine Care of Cancer Patients. BC Decker Inc, 2009.
      10. Hymes SR, Strom EA. Radiation Dermatitis. In: Internal Medicine Care of Cancer Patients. BC Decker Inc.,, 2009.
      11. Pross S, Hymes S. Fungal Infections. In: Infectious Disease for Medical Students. McGraw Hill Publications, 135-153, 2006.
      12. Hymes S, Duvic M. Cutaneous Candidiasis. In: Candidiasis: Pathogenesis, Diagnosis, and Treatment. Raven Press, 159-166, 1992.
      13. Hymes S, Hood A, Farmer E. Graft-versus-host disease. In: Immunologic Diseases of the Skin. Appleton & Lange Publications, 509-523, 1991.
      14. Drucker C, Hymes S, Jordon R. Vitiligo. In: Immunologic Diseases of the Skin. Appleton & Lange Publications, 419-426, 1991.
      15. Hymes S. Disorders of collagen. In: Pathology of the Skin. Appleton & Lange Publications, 408-418, 1990.
      16. Hymes SR. Toxic epidermal necrolysis. In: Current Therapy in Dermatology-2. BC Decker, Inc, 49-50, 1988.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top